VC  Boston Millennia Partners

http://www.millenniapartners.com





     Office Locations:

30 Rowes Wharf, Suite 400
Boston, MA 02110
Phone: 617-428-5150
Fax: 617-428-5160

 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Communications & Networking
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 1979, Boston Millennia Partners provides private equity financing to companies in the telecommunications, IT and Business Services, healthcare and life sciences industries. The firm's capital base exceeds over $700 million and its limited partners include investors from a dozen countries. The majority of the firm's investments are in early rounds, however Boston Millenia invests in companies at various stages of development, from the first round of institutional funding to later stage expansion opportunities. The firm seeks to invest up to $15 million in any single portfolio company. Typical first round investments range from $3 million to $10 million, with follow-on financings often doubling the original capital commitment. In select cases, Boston Millennia has made initial investments of as little as $1 million with the expectation that the fund will significantly increase its investment through later commitments. The firm invests throughout the U.S. and Canada but has a preference for companies located in the eastern U.S. Within the past twenty years, core companies in the firm's portfolio have completed over 160 strategic acquisitions.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    A. Dana Callow Managing General Partner
    Bruce R. Tiedemann Partner and CFO
    Martin J. Hernon General Partner
    Patrick J. Fortune Ph.D. Partner
    Robert S. Sherman General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/21/2017


      Bivarus


      NC


      $4,000,000


      Series B


     

    Portfolio companies include:


      Arthrosurface
        web link


      Athenix
        web link


      Bivarus
        web link


      Bright Horizons
        web link


      Cardiomems
        web link


      Coapt Systems
        web link


      Collegium Pharma
        web link


      Concentrix
        web link


      Cota
        web link


      eMed Technologies
        web link


      Epigenesis Pharmaceuticals
        web link


      EPIX Pharmaceuticals


      Galt Associates
        web link


      GlycoFi
        web link


      Histogenics
        web link


      ILEX
        web link


      iParty
        web link


      MedAptus
        web link


      Medical Management of New England
        web link


      MedSpan
        web link


      Nextel
        web link


      Novalar
        web link


      Parexel International
        web link


      PHT
        web link


      Proteome
        web link


      Tektagen
        web link


      Zalicus
        web link


     

    Recent News:


      There is no recent news for Boston Millennia Partners.